Should Antimicrobial Resistance Limit Access to an Organ Transplant?
AMA J Ethics
; 26(5): E367-372, 2024 May 01.
Article
en En
| MEDLINE
| ID: mdl-38700520
ABSTRACT
Burkholderia cenocepacia (B cenocepacia) is a gram-negative bacteria associated with significant morbidity and mortality following lung transplantation. Most US transplant programs consider B cenocepacia colonization to be an absolute contraindication to transplantation. This article argues that, if clinicians have good clinical reasons to expect poor outcomes for patients with B cenocepacia, then offering transplantation anyway is an abrogation of clinicians' fiduciary duties. This article also discusses other fiduciary obligations transplant programs might have to patients with B cenocepacia, such as referring to another transplant center, considering novel treatment options, and investigating how the infection's virulence factors stratify that patient's risk for poor transplant outcomes.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trasplante de Pulmón
/
Infecciones por Burkholderia
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
AMA J Ethics
Año:
2024
Tipo del documento:
Article